Arrhythmias & electrophysiology

Impact of early vs. delayed atrial fibrillation catheter ablation on atrial arrhythmia recurrences

Eur Heart JPublished Randomised controlled trial

Corrected 23 Oct 2026: Measure wording clarified; no values changed.

Authors' conclusion

Compared with an early ablation strategy, delaying AF ablation by 12 months for AAD management did not result in reduced ablation efficacy.

Study context

Population
Patients with symptomatic atrial fibrillation (AF) referred to a tertiary centre89 completed (48 vs 41)
Participants
100 patients
Comparison
Early vs delayed AF catheter ablation
Primary endpoint
Atrial arrhythmia free survival
Follow-up
12 months post-ablation
Methodological detailssingle tertiary centre, 1:1 randomisation, Pulmonary vein isolation achieved in 100% of patients
  • Single tertiary centre
  • 1:1 randomisation
  • Pulmonary vein isolation achieved in 100% of patients

Primary result

Freedom from recurrent arrhythmia · 12 months

Hazard ratio

1.12

95% CI 0.59–2.13, event not clearly stated

P = 0.7

By group

As reported in the abstract

Secondary outcomes

Antiarrhythmic drug use · 12 months

P = 0.8

Median

OutcomeEarlyDelayedP value
AF burden0% (IQR 3.2)0% (IQR 5)P = 0.66
AF burden, paroxysmal AF (subgroup)0% (IQR 1.1)0% (IQR 4.5)P = 0.78
AF burden, persistent AF (subgroup)0% (IQR 22.8)0% (IQR 5.6)P = 0.45

Original publication

Impact of early vs. delayed atrial fibrillation catheter ablation on atrial arrhythmia recurrences. Eur Heart J. Published 16 April 2023. doi:10.1093/eurheartj/ehad247

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.